Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Articles published by Vaccitech plc

Vaccitech to Host KOL Webinar on Seeking a Functional Cure for Chronic Hepatitis B on September 20, 2023
From Vaccitech plc
Via GlobeNewswire
Tickers VACC
Vaccitech Reports Second Quarter 2023 Financial Results and Recent Corporate Developments
From Vaccitech plc
Via GlobeNewswire
Tickers VACC
Vaccitech to Present Positive Final Data at EASL Congress for Phase 1b/2 HBV002 Study in Adults with Chronic Hepatitis B
From Vaccitech plc
Via GlobeNewswire
Tickers VACC
Vaccitech Doses First Patient in PCA001, a Prostate Cancer Phase 1/2 Clinical Trial of VTP-850 Immunotherapeutic Candidate in Men with Rising PSA after Definitive Local Therapy
From Vaccitech plc
Via GlobeNewswire
Tickers VACC
Vaccitech Presents Interim Data from Phase 1b/2 Study of VTP-200 at 35th Annual International Papillomavirus Conference (IPVC) Highlighting Favorable Tolerability and Immunogenicity Profile
From Vaccitech plc
Via GlobeNewswire
Tickers VACC
Vaccitech Announces Positive Topline Final Data for HBV002 Study in People with Chronic Hepatitis B
From Vaccitech plc
Via GlobeNewswire
Tickers VACC
Vaccitech Reports Full-Year 2022 Financial Results and an Update on Corporate Developments
From Vaccitech plc
Via GlobeNewswire
Tickers VACC
Vaccitech’s VTP-200 Ph 1b/2 Study Demonstrates Favorable Tolerability and Immunogenicity Profile at Interim Analysis in Women with Low-Grade Human Papillomavirus (HPV)-related Cervical Lesions
From Vaccitech plc
Via GlobeNewswire
Tickers VACC
Vaccitech Appoints Industry Veteran, Nadège Pelletier, Ph.D., as Chief Scientific Officer
From Vaccitech plc
Via GlobeNewswire
Tickers VACC
Vaccitech Reports Third Quarter 2022 Financial Results and Recent Corporate Developments
From Vaccitech plc
Via GlobeNewswire
Tickers VACC
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.